<p>Convergence and extension (C&amp;E) cell movements that elongate the primary embryonic axis are precisely timed during vertebrate gastrulation, but mechanisms controlling their onset remain unknown. Using zebrafish embryonic explants that recapitulate C&amp;E and its timing, we identified <i>sulfatase modifying factor 2</i> (<i>sumf2</i>) as a candidate trigger gene for C&amp;E onset. <i>sumf2</i> and its paralog <i>sumf1</i> encode negative and positive sulfatase regulators, respectively, whose expression levels invert and increase heparan sulfate sulfation during gastrulation. Overexpressing <i>sumf1</i> or <i>sumf2</i> causes delayed or precocious C&amp;E, respectively, whereas their loss shifts C&amp;E timing in the opposite direction. We identified Sulf1, a modifier of heparan sulfate proteoglycans (HSPGs), as their key downstream effector and found that altering heparan sulfate sulfation levels shifts C&amp;E onset and suppresses <i>sumf1</i> and <i>sumf2</i> mutant phenotypes. This work supports a model in which <i>sumf2</i> expression reduces sulfatase activity, rewriting HSPG sulfation patterns to promote the onset of C&amp;E morphogenesis.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Sulfatase modifying factors control the timing of zebrafish convergence and extension morphogenesis

  • Ailen Soledad Cervino,
  • Amrita Basu,
  • Ryan J. Weiss,
  • Gursimran Kaur Bajwa,
  • Rubén Marín-Juez,
  • Sandra L. Grimm,
  • Cristian Coarfa,
  • Margot Kossmann Williams

摘要

Convergence and extension (C&E) cell movements that elongate the primary embryonic axis are precisely timed during vertebrate gastrulation, but mechanisms controlling their onset remain unknown. Using zebrafish embryonic explants that recapitulate C&E and its timing, we identified sulfatase modifying factor 2 (sumf2) as a candidate trigger gene for C&E onset. sumf2 and its paralog sumf1 encode negative and positive sulfatase regulators, respectively, whose expression levels invert and increase heparan sulfate sulfation during gastrulation. Overexpressing sumf1 or sumf2 causes delayed or precocious C&E, respectively, whereas their loss shifts C&E timing in the opposite direction. We identified Sulf1, a modifier of heparan sulfate proteoglycans (HSPGs), as their key downstream effector and found that altering heparan sulfate sulfation levels shifts C&E onset and suppresses sumf1 and sumf2 mutant phenotypes. This work supports a model in which sumf2 expression reduces sulfatase activity, rewriting HSPG sulfation patterns to promote the onset of C&E morphogenesis.